DYRK1A and Dravet syndrome: However, recent research has identified the Dual specificity tyrosine phosphorylation regulated kinase 1 A (DYRK1A) gene and protein as a potential therapeutic target for DS and other diseases due to its dose-dependent nature (Feki and Hibaoui, 2018; Liu et al., 2022).